Risultati della ricerca - Lambros Tselikas
- Mostra 1 - 20 risultati su 28
- Vai alla pagina seguente
-
1
Intratumoral immunotherapy: using the tumor as the remedy di Aurélien Marabelle, Lambros Tselikas, Thierry de Baère, Roch Houot
Pubblicazione 2017Revisão -
2
-
3
-
4
Percutaneous thermal ablation of primary lung cancer di Thierry de Baère, Lambros Tselikas, Vittorio Catena, Xavier Buy, Frédèric Deschamps, Jean Palussière
Pubblicazione 2016Revisão -
5
Imaging of neuroendocrine tumors of the pancreas di Clarisse Dromain, Désirèe Deandreis, Jean–Yves Scoazec, Diane Goèré, Michel Ducreux, Éric Baudin, Lambros Tselikas
Pubblicazione 2016Revisão -
6
-
7
GEP-NETS UPDATE: Interventional radiology: role in the treatment of liver metastases from GEP-NETs di Thierry de Baère, Frédèric Deschamps, Lambros Tselikas, Michel Ducreux, David Planchard, Ernesto Pearson, A. Berdelou, Sophie Leboulleux, Dominique Élias, Éric Baudin
Pubblicazione 2014Revisão -
8
-
9
-
10
Thermal Ablation Combined with Immune Checkpoint Blockers: A 10-Year Monocentric Experience di Baptiste Bonnet, Louis Tournier, Frédèric Deschamps, Steven Yevich, Aurélien Marabelle, Caroline Robert, Laurence Albigès, Benjamin Besse, V Bonnet, Thierry de Baère, Lambros Tselikas
Pubblicazione 2024Artigo -
11
Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year di Thierry de Baère, Lambros Tsélikas, David A. Woodrum, Fereidoun Abtin, Peter J. Littrup, Frédèric Deschamps, Robert D. Suh, Hussein D. Aoun, Matthew R. Callstrom
Pubblicazione 2015Artigo -
12
-
13
Interventional Radiology for Local Immunotherapy in Oncology di Lambros Tselikas, Stéphane Champiat, Rahul A. Sheth, Steve Yevich, Samy Ammari, Frédèric Deschamps, Siham Farhane, Charles Roux, Sandrine Susini, Séverine Mouraud, Alexandre Delpla, Thibault Raoult, Caroline Robert, Christophe Massard, Fabrice Barlési, Jean‐Charles Soria, Aurélien Marabelle, Thierry de Baère
Pubblicazione 2021Revisão -
14
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non–small cell lung cancer di Francesco Facchinetti, Ludovic Lacroix, Laura Mezquita, Jean–Yves Scoazec, Yohann Loriot, Lambros Tselikas, Anas Gazzah, Étienne Rouleau, Julien Adam, Stefan Michiels, Christophe Massard, Fabrice André, Ken A. Olaussen, Gilles Vassal, Karen Howarth, Benjamin Besse, Jean‐Charles Soria, Luc Friboulet, David Planchard
Pubblicazione 2020Artigo -
15
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy di Laurent Dercle, Samy Ammari, Elvire Roblin, Amélie Bigorgne, Stéphane Champiat, Lokmane Taihi, Athèna Plaian, Sophie Hans, Sara Lakiss, Lambros Tsélikas, Mathieu Rouanne, Éric Deutsch, Lawrence H. Schwartz, Mithat Gönen, Jessica Flynn, Christophe Massard, Jean‐Charles Soria, Caroline Robert, Aurélien Marabelle
Pubblicazione 2022Artigo -
16
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance di Yohann Loriot, Aurélien Marabelle, Jean‐Philippe Guégan, François‐Xavier Danlos, Benjamin Besse, Nathalie Chaput, Christophe Massard, David Planchard, Caroline Robert, Caroline Even, Mohamed Khettab, Lambros Tselikas, Luc Friboulet, Fabrice André, Imane Nafia, François Le Loarer, Jean‐Charles Soria, Alban Bessede, Antoîne Italiano
Pubblicazione 2021Artigo -
17
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial di Étienne Garin, Lambros Tselikas, Boris Guiu, Julia Chalaye, Yan Rolland, Thierry de Baère, Éric Assenat, Vania Tacher, Xavier Palard, Désirèe Deandreis, Denis Mariano‐Goulart, Giuliana Amaddeo, Karim Boudjéma, Antoine Hollebecque, Mohamad Azhar Meerun, Helen Regnault, Éric Vibert, Boris Campillo‐Gimenez, Julien Edeline
Pubblicazione 2024Artigo -
18
Understanding and Overcoming Resistance to Selective FGFR inhibitors Across <i>FGFR2</i>-Driven Malignancies di Francesco Facchinetti, Yohann Loriot, Floriane Brayé, Damien Vasseur, Rastislav Bahleda, Ludovic Bigot, Rémy Barbé, Catline Nobre, David Combarel, Stefan Michiels, Antoîne Italiano, Cristina Smolenschi, Lambros Tselikas, Jean–Yves Scoazec, Santiago Ponce-Aix, Benjamin Besse, Fabrice André, Ken A. Olaussen, Antoine Hollebecque, Luc Friboulet
Pubblicazione 2024Artigo -
19
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients di J. Chen, Fabio Facchinetti, Floriane Brayé, Andrey A. Yurchenko, Ludovic Bigot, Santiago Ponce, David Planchard, Anas Gazzah, Sergey I. Nikolaev, Stefan Michiels, Damien Vasseur, Ludovic Lacroix, Lambros Tselikas, Catline Nobre, Ken A. Olaussen, Fabrice André, Jean–Yves Scoazec, Fabrice Barlési, Jean‐Charles Soria, Yohann Loriot, Benjamin Besse, Luc Friboulet
Pubblicazione 2022Artigo -
20
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer di Antonin Lévy, Daphné Morel, Matthieu Texier, Roger Sun, Jérôme Durand-Labrunie, María E. Rodríguez-Ruiz, S. Racadot, S. Supiot, Nicolas Magné, Stacy Cyrille, G. Louvel, Christophe Massard, Loïc Verlingue, Fanny Bouquet, Alberto Bustillos, Lisa Bouarroudj, Clément Quevrin, Céline Clémenson, Michele Mondini, Lydia Meziani, Lambros Tsélikas, Rastilav Bahleda, Antoine Hollebecque, Éric Deutsch
Pubblicazione 2024Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Cancer
Oncology
Radiology
Cancer research
Biology
Immunotherapy
Ablation
Lung cancer
Immunology
Surgery
Clinical trial
Cryoablation
Immune system
Genetics
Immune checkpoint
Percutaneous
Radiation therapy
Radiofrequency ablation
Receptor
Biochemistry
Clinical endpoint
Colorectal cancer
Crizotinib
Economics
Gene
Interventional radiology
Lung
Malignant pleural effusion